Faster Biotherapeutic Protein Production With the New TransIT-PRO(TM) Transfection Kit

MADISON, Wis., Aug. 18 Mirus Bio now offers a new transfection kit ideal for biotherapeutic protein production in large pharma and biotech settings. Mirus Bio's new TransIT-PRO(TM) Kit will decrease time to produce usable protein by maximizing target protein yields through transient transfection. TransIT-PRO(TM) Kit uses animal origin free components designed for high and reproducible protein yield in suspension CHO and 293 derived cells. Since it is compatible with varied media formulations, the same media can be used for both transient and stable expression. TransIT-PRO(TM) outperforms linear PEI in protein yield and reproducibility while providing a cost-effective alternative to FreeStyle(TM) MAX.

(Logo: http://photos.prnewswire.com/prnh/20100818/CG52502LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100818/CG52502LOGO)

With TransIT-PRO(TM) you will:

Visit www.mirusbio.com for all your transfection needs including access to the citations database, data, protocols, technical support, inquiries about bulk pricing or to place an order.

The Transfection Experts

More than 15 years of gene delivery expertise.

Mirus pioneered scientific breakthroughs in non-viral gene delivery. These advancements established our products as industry leading transfection reagents. At Mirus, we continue to grow our expertise in nucleic acid delivery research and products to better serve you.

-- Achieve high protein yield in suspension CHO and 293 cells -- Experience compatibility with multiple CHO media formulations -- Obtain reproducible protein expression with minimal optimization

SOURCE Mirus Bio LLC

Latest Press Release on News on IT in Healthcare

DRUGDOCS® Launches Enhanced AI-Integrated Platform at the American College of Physicians Internal Medicine Meeting 2024

KANATA, ON , April 18, 2024 /PRNewswire/ - Today, DRUGDOCS® Inc., a leader in delivering authoritative drug information to healthcare professionals, announced the rollout of a sig...

Scopio Labs Receives Groundbreaking FDA Clearance for First-Ever Digital Bone Marrow Aspirate Application

The company's 3rd FDA clearance accelerates the shift to AI-powered digital hematopathology, enhancing diagnostic speed and patient care TEL AVIV , Israel , April 17, 2024 /PR...

Tel Aviv Sourasky Medical Center (TASMC) partners with the AI innovator NeuroBrave to bring Generative AI into the field of BCI (Brain-Computer Interfaces)

The collaboration will yield real-time translation of thoughts and intentions, allowing completely paralyzed patients to intuitively communicate with those around them, and operate compu...

Clarius and ThinkSono Introduce a New AI-Guided Ultrasound System Enabling Rapid Assessments of DVTs

Having achieved CE Mark for sales in Europe and the UK, ThinkSono is now collaborating with Clarius on clinical studies in the United States to prepare for FDA submission VANCO...

CDL Nuclear Technologies Launches New Mobile Cardiac PET/CT Trailer

CDL now offers three solutions for cardiovascular imaging needs WEXFORD, Pa. , April 4, 2024 /PRNewswire/ -- CDL Nuclear Technologies, a pioneer in advanced diagnostic solution...